Unsurprisingly, the tumor volume and weight significantly decreased in A3A overexpression group compared with control group after anti-PD-1 treatment, which indicating that A3A overexpression enhanced immunotherapy efficacy (Figure 8G-I). Here, PDCD1 is linked to neoplasm.